BioXcel Therapeutics, Inc. (BTAI)

45.20
2.24 5.21
NASDAQ
Prev Close 42.96
Open 44.50
Day Low/High 39.50 / 46.00
52 Wk Low/High 13.77 / 71.50
Volume 731.82K
Exchange NASDAQ
Shares Outstanding 24.37B
Market Cap 1.15B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech M&A Picks Up: Lessons for Investors and Potential Targets

Biotech M&A Picks Up: Lessons for Investors and Potential Targets

The euphoria in biotech stocks Monday was a nice change of pace. It also brought to the forefront some lessons about M&A in this industry.

This Is Great Action for Stock Pickers Right Now

This Is Great Action for Stock Pickers Right Now

Stick to themes like biotechnology, SPACs, EV batteries, and others.

2 Small Biotechs That Have Attracted My Attention and My Cash

2 Small Biotechs That Have Attracted My Attention and My Cash

BioXcel Therapeutics and Avadel Pharmaceuticals are new additions to my personal portfolio based on their promising drug prospects.

Stubborn Market Refuses to Budge From Uptrend

Stubborn Market Refuses to Budge From Uptrend

Most notable is how the coronavirus issue is having no negative impact.